ES Clinical Research Group
Clinical Research Site Management Organization Based in Queens, NY

Executing clinical trials that lead to the launch of lifesaving drugs requires more than just a protocol and a facility. Many research-naïve physicians and clinics are interested in conducting clinical trials but lack the necessary manpower and expertise. An experienced site management organization can facilitate promising clinical trials, secure sponsors, and provide resources to navigate the clinical trial start-up, enrollment, retention and close-out process seamlessly.

Stella Gurgova, Founder and CEO of ES Clinical Research Group (ESCRG), a trusted SMO, is an industry veteran with almost 15 years of experience in clinical research management and administration. Under her esteemed guidance, ESCRG streamlines clinical research and leads clinical trials from initiation to close-out. ESCRG offers comprehensive services to clinical research sites specializing in various therapeutic areas, including neurology, cardiology, pain management, endocrinology, women’s and general health.

Founded just three years ago, ES Clinical Research Group (ESCRG) has already made significant strides in the industry. ESCRG is dedicated to supporting a network of clinical research sites, as well as research-naïve clinics and physicians across the Unites States in completing Phase I-IV drug and device clinical trials. ESCRG connects the most efficient and reliable clinical research sites and patients with pharma and biotech companies, in addition to collaborating with physicians on research publications, editorials, and manuscript preparation.

“We handhold research-naive physicians and clinics through the process, helping them identify suitable clinical research studies, manage clinical trials on their behalf, and ensure their business succeeds,” says Gurgova.

Effectiveness and professionalism are hallmarks of ESCRG, which follows a systematic service delivery approach. The team begins by scheduling an initial call with each new client to delve into their practice and understand their interests, specialties, and target disease areas. Armed with this in-depth knowledge, they create a detailed client profile to explore and identify relevant clinical research studies for each site. For instance, if a site focuses on general health conditions, the team finds and recommends studies focused on diabetes, hypertension, Alzheimer’s, and migraines.

Once study recommendations are received, ESCRG ensures the study aligns with the site’s patient population and confirms the availability of physicians to conduct the trials. ESCRG conducts database reviews and/or drives recruitment campaigns to identify eligible participants. ESCRG provides a large scale of services including study identification, feasibility, contract/budgeting, study protocol and procedures training, patient recruitment/ retention, patient study visits, informed consents, monitoring visit preparation and data entry. ESCRG ensures all sites comply with good clinical practice, IRB and regulatory regulations.

Client success remains a top priority for ESCRG. Collaborating with numerous clinical research sites across the U.S. in states, including New York, California, Texas, Florida, and Virginia, ESCRG facilitates their ability to independently identify suitable studies.

ESCRG’s exemplary services and strong reputation stem from Gurgova’s unwavering passion for clinical research. Beginning her career as a clinical research coordinator in neuro-oncology, later she was a research director in a large neurology clinic. Presently holding a master’s degree in clinical research administration, she is currently pursuing her Doctoral Degree in Health Science. With an entrepreneurial spirit and a drive to expedite the launch of both investigational and approved drugs ingrained in her work ethos, she meticulously trains her team to excel in every project.

Through its steadfast commitment to clinical research excellence, ESCRG has earned recognition as a trusted SMO that transforms successful clinical trial execution into a tangible reality for all stakeholders.